Comparative trifecta outcomes following radical prostatectomy versus focal therapy for localized prostate cancer: Functional and oncologic trade-offs in a contemporary cohort
Organ-specific side effects following curative-intent radiotherapy and radical prostatectomy for non-metastatic prostate cancer: A population-based cohort study
Prognostic value of interim PSMA-PET total tumour volume for overall survival within ENZA-p, a randomised phase 2 trial of enzalutamide versus enzalutamide plus [177Lu] Lu-PSMA-617 (ANZUP1901)